European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

Clin Microbiol Infect. 2009 Dec;15(12):1067-79. doi: 10.1111/j.1469-0691.2009.03099.x.

Abstract

Clostridium difficile infection (CDI) is a potentially fatal illness with an increasing incidence worldwide. Despite extensive ongoing research into CDI treatment, management of CDI still poses important problems, such as a high propensity to relapse and refractoriness to treatment, especially when there is an ileus and oral drugs cannot be administered. This guideline evaluates the available literature, discusses criteria for disease severity and provides recommendations for CDI treatment, indicating level of evidence and strength of recommendation.

Publication types

  • Practice Guideline

MeSH terms

  • Clostridium Infections / drug therapy*
  • Clostridium Infections / microbiology
  • Clostridium Infections / physiopathology
  • Clostridium Infections / therapy*
  • Clostridium difficile*
  • Enterocolitis, Pseudomembranous / drug therapy*
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / physiopathology
  • Enterocolitis, Pseudomembranous / therapy*
  • Health Planning Guidelines
  • Humans